SCHEMBL10461990

SCHEMBL10461990

CS(=O)(=O)Nc1ccc(OCCCBr)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.71
RAB9A P51151 2/20 0.71
SMN1; SMN2 Q16637 3/20 0.56
HPGD P15428 3/20 0.56
AR P10275 1/20 0.56
KCNH2 Q12809 2/20 0.56
CACNA1F O60840 1/20 0.56
CHRM2 P08172 1/20 0.56
ACHE P22303 1/20 0.56
AGTR1 P30556 1/20 0.56
DRD3 P35462 1/20 0.56
CACNA1D Q01668 1/20 0.56
CACNA1S Q13698 1/20 0.56
CACNA1C Q13936 1/20 0.56
LMNA P02545 4/20 0.55
MAPK1 P28482 2/20 0.55
LTA4H P09960 1/20 0.55
PGR P06401 1/20 0.51
GRIN1 Q05586 4/20 0.50
GRIN2B Q13224 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6575574 0.92 NPC1 (0.69) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL14113144 0.86 NPC1 (0.93) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL9732793 0.85 NPC1 (0.73) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL8795293 0.83 NPC1 (0.71) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL9732903 0.83 NPC1 (0.71) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL9733253 0.82 NPC1 (0.69) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL10426270 0.81 NPC1 (0.68) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL5145130 0.81 NPC1 (0.69) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL92225 0.81 NPC1 (0.69) NPC1RAB9ASMN1; SMN2HPGDAR
SCHEMBL9123987 0.81 NPC1 (0.69) NPC1RAB9ASMN1; SMN2HPGDAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4950674-A Arylalkylheterocyclic amines,N-substituted by aryloxyalkyl group in a method for allergy treatment A. H. ROBINS COMPANY, INCORPORATED (US) 1990-08-21 US disclosed
US-4810713-A Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment A. H. ROBINS COMPANY, INCORPORATED (US) 1989-03-07 US disclosed
EP-0235463-A2 N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) (US) 1987-09-09 EP disclosed